Epilepsy – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026
Epilepsy Emerging Therapy and TPP Insights Thelansis’s “Epilepsy Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), trial designs, and KOL insights on key emerging therapies and key drug development opportunities in the indication . Epilepsy Overview Epilepsy is a chronic neurological condition marked by recurrent seizures, and while a broad set of anti-seizure medications has long formed the backbone of treatment, a persistent share of patients continue to experience seizures despite multiple drug options, a category known as drug-resistant epilepsy that remains one of neurology’s most durable unmet needs. For these patients, care has traditionally escalated toward surgical removal of the seizure-generating brain region or implantable neuromodulation devices that interrupt abnormal electrical activity, alongside dietary approaches in sele...